FR2485540B1 - - Google Patents
Info
- Publication number
- FR2485540B1 FR2485540B1 FR8014512A FR8014512A FR2485540B1 FR 2485540 B1 FR2485540 B1 FR 2485540B1 FR 8014512 A FR8014512 A FR 8014512A FR 8014512 A FR8014512 A FR 8014512A FR 2485540 B1 FR2485540 B1 FR 2485540B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
- A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (31)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8014512A FR2485540A1 (fr) | 1980-06-30 | 1980-06-30 | Nouveaux derives antibiotiques des cephalosporines, leur procede de preparation et les medicaments en contenant |
GR65352A GR75711B (pt) | 1980-06-30 | 1981-06-25 | |
GR65351A GR75706B (pt) | 1980-06-30 | 1981-06-25 | |
EP81401027A EP0044238B1 (fr) | 1980-06-30 | 1981-06-26 | Dérivés de céphalosporines sulfoxydes, procédé de préparation et compositions pharmaceutiques en contenant |
DK283381A DK283381A (da) | 1980-06-30 | 1981-06-26 | Fremgangsmaade til fremstilling af 1,2,4-triazinylthiomethyl-3-cephem-sulfoxid |
EP81401028A EP0043756B1 (fr) | 1980-06-30 | 1981-06-26 | 1,2,4-Triazinylthiométhyl-3-céphèmes sulfoxydes, procédé de préparation et compositions pharmaceutiques en contenant |
AT81401028T ATE7394T1 (de) | 1980-06-30 | 1981-06-26 | 1,2,4-triazinylthiomethyl-3-cephem-sulfoxyde, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. |
DE8181401027T DE3162109D1 (en) | 1980-06-30 | 1981-06-26 | Cephalosporin sulfoxides, process for their preparation and pharmaceutical compositions containing them |
DE8181401028T DE3163490D1 (en) | 1980-06-30 | 1981-06-26 | 1,2,4-triazinylthiomethyl-3-cephem sulfoxides, process for their preparation and pharmaceutical compositions containing them |
AT81401027T ATE6066T1 (de) | 1980-06-30 | 1981-06-26 | Cephalosporinsulfoxyd-verbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. |
DK283281A DK283281A (da) | 1980-06-30 | 1981-06-26 | Fremgangsmaade til fremstilling af sulfoxidderivater af cephalosporiner |
IE1453/81A IE51359B1 (en) | 1980-06-30 | 1981-06-29 | Derivatives of cephalosporin sulphoxides,process for their preparation and pharmaceutical compositions containing them |
NO812214A NO812214L (no) | 1980-06-30 | 1981-06-29 | Fremgangsmaate for fremstilling av 3-(hydroksy-1,2,4-triazinyl)tiometyl-cefalosporiner |
NZ197564A NZ197564A (en) | 1980-06-30 | 1981-06-29 | Cephalosporin sulphoxide derivatives and pharmaceutical compositions |
PT73283A PT73283B (fr) | 1980-06-30 | 1981-06-29 | Procede de preparation d'oxides de cephalosporines |
ZA814394A ZA814394B (en) | 1980-06-30 | 1981-06-29 | Derivatives of cephalosporine sulphoxides:preparation and pharmaceutical composition |
NZ197563A NZ197563A (en) | 1980-06-30 | 1981-06-29 | 3-(1,2,4-triazinylthiomethyl)-3-cephem-1-sulphoxide derivatives |
NO812215A NO159798C (no) | 1980-06-30 | 1981-06-29 | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporin-oksyder. |
ZA814392A ZA814392B (en) | 1980-06-30 | 1981-06-29 | 1,2,4-triazinylthiomethyl-3-cepheme sulfoxide procedure for preparation and deledic forms |
PT73284A PT73284A (fr) | 1980-06-30 | 1981-06-29 | Procede de preparation de derives de cephalosporines sulfoxides |
IE1452/81A IE51358B1 (en) | 1980-06-30 | 1981-06-29 | 1,2,4-triazinylthiomethyl-3-cephem sulfoxides,process for their preparation and pharmaceutical compositions containing them |
AU72410/81A AU7241081A (en) | 1980-06-30 | 1981-06-30 | Cephalosporins |
CA000380874A CA1175806A (en) | 1980-06-30 | 1981-06-30 | Derivatives of cephalosporine sulphoxides : preparation and pharmaceutical composition |
CA000380872A CA1173434A (en) | 1980-06-30 | 1981-06-30 | 1,2,4-triazinylthiomethyl-3-cepheme sulfoxide procedure for preparation and deledic forms |
MX10176881U MX6880E (es) | 1980-06-30 | 1981-06-30 | Procedimiento de preparacion de 1,2,4-triaziniltiometil-3-cefem sulfoxidos |
AU72411/81A AU543165B2 (en) | 1980-06-30 | 1981-06-30 | Cephalosporins |
JP10076481A JPS5738785A (en) | 1980-06-30 | 1981-06-30 | 3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same |
JP10076581A JPS5738786A (en) | 1980-06-30 | 1981-06-30 | Cephalosporin sulfoxide derivative, manufacture and drug composition containing it |
ES503563A ES503563A0 (es) | 1980-06-30 | 1981-06-30 | Procedimiento de preparacion de cefalosporinas oxidas |
ES503562A ES8204996A1 (es) | 1980-06-30 | 1981-06-30 | Procedimiento de preparacion de 3-(1,2,4-hidroxitriazinil) tiometil cefalosporinas |
US06/525,797 US4604387A (en) | 1980-06-30 | 1983-08-23 | 1,2,4-triazinylthiomethyl-3-cephem sulfoxides, and a procedure for their preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8014512A FR2485540A1 (fr) | 1980-06-30 | 1980-06-30 | Nouveaux derives antibiotiques des cephalosporines, leur procede de preparation et les medicaments en contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2485540A1 FR2485540A1 (fr) | 1981-12-31 |
FR2485540B1 true FR2485540B1 (pt) | 1984-02-24 |
Family
ID=9243670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8014512A Granted FR2485540A1 (fr) | 1980-06-30 | 1980-06-30 | Nouveaux derives antibiotiques des cephalosporines, leur procede de preparation et les medicaments en contenant |
Country Status (4)
Country | Link |
---|---|
JP (2) | JPS5738785A (pt) |
AU (1) | AU7241081A (pt) |
FR (1) | FR2485540A1 (pt) |
ZA (2) | ZA814392B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4367228A (en) * | 1980-10-29 | 1983-01-04 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compound and composition |
DE3207840A1 (de) * | 1982-03-04 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | "cephalosporinderivate und verfahren zu ihrer herstellung" |
FR2546520B1 (fr) * | 1983-05-27 | 1985-08-30 | Sanofi Sa | Nouveaux composes antibiotiques derives des cephalosporines |
BRPI0413908A (pt) * | 2003-08-25 | 2006-10-24 | Revaax Pharmaceuticals Llc | formulação farmacêutica neuroterapêutica em forma de dosagem oral, composto, e, método de tratamento de um distúrbio comportamental ou um distúrbio cognitivo |
-
1980
- 1980-06-30 FR FR8014512A patent/FR2485540A1/fr active Granted
-
1981
- 1981-06-29 ZA ZA814392A patent/ZA814392B/xx unknown
- 1981-06-29 ZA ZA814394A patent/ZA814394B/xx unknown
- 1981-06-30 AU AU72410/81A patent/AU7241081A/en not_active Abandoned
- 1981-06-30 JP JP10076481A patent/JPS5738785A/ja active Pending
- 1981-06-30 JP JP10076581A patent/JPS5738786A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPS5738786A (en) | 1982-03-03 |
FR2485540A1 (fr) | 1981-12-31 |
AU7241081A (en) | 1982-01-07 |
ZA814392B (en) | 1982-07-28 |
JPS5738785A (en) | 1982-03-03 |
ZA814394B (en) | 1982-09-29 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CA | Change of address | ||
CD | Change of name or company name | ||
TP | Transmission of property | ||
ST | Notification of lapse |